Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023
February 07, 2023 at 01:00 am EST
Share
Noevir Holdings Co., Ltd. provided consolidated earnings guidance for the six months ending March 2023 and for the fiscal year ending September 30, 2023. For the six months, the company expects net sales of JPY 30,200 million, operating profit of JPY 5,300 million, profit attributable to owners of parent of JPY 2,400 million and basic earnings per share of JPY 70.27.
For the full year, the company expects net sales of JPY 61,600 million, operating profit of JPY 10,700 million, profit attributable to owners of parent of JPY 7,700 million and basic earnings per share of JPY 225.43.
Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023
NOEVIR HOLDINGS CO., LTD. 
